Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Immunization Strategies in Low-Risk Infants. Tsung S, Zeng YB, Shah K, Asch SM, et al. Pediatrics 2026 Feb 20:e2025071558. doi: 10.1542/peds.2025-071558.

Read + Share

Amedeo Smart

Independent Medical Education

Tsung S, Zeng YB, Shah K, Asch SM, et al. Cost-Effectiveness of Nirsevimab and Maternal RSVpreF Immunization Strategies in Low-Risk Infants. Pediatrics 2026 Feb 20:e2025071558. doi: 10.1542/peds.2025-071558.
PMID: 41713490